We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Routine Screenings Uncover Hidden Carbon Monoxide Poisoning

By HospiMedica staff writers
Posted on 26 Feb 2008
Screening all emergency room patients for carbon monoxide (CO) poisoning is a potentially life-saving practice that can be achieved even in a high-volume urban hospital, claims a new study.

Emergency physicians at Rhode Island Hospital (Providence, USA) screened 14,438 patients visiting the hospital's emergency department for exposure to CO, a highly toxic gas that can cause brain and heart damage and even death. More...
The emergency room staff used a portable, non-invasive pulse CO-oximeter (a device similar to the standard pulse oximeter) to screen patients who presented to the emergency department for various concerns over a three-month span. These measurements were documented along with initial vital signs and oxygen saturation as part of the standard triage process.

The researchers identified 28 cases of CO poisoning, 11 of which were unexpected and identified only with routine screening. None of these patients exhibited the usual signs of CO poisoning, such as headaches, dizziness, and flu-like symptoms. Nearly a third of the patients required hyperbaric oxygen treatment, in which 100% oxygen is delivered under high pressure in a specialized chamber to reduce the amount of CO in the blood and return oxygen levels to normal. Overall, four of the 11 patients were smokers. Patients diagnosed with CO poisoning were interviewed by the researchers to determine how they used the information they were provided in the emergency department after being discharged. Those judged to have environmental CO poisoning were also contacted by telephone and asked if they discovered the source of CO, whether the fire department was contacted, the incidence of recurrent similar symptoms, and whether a smoke or CO detector was purchased. The study was published early online on January 26, 2008, in The Journal of Emergency Medicine.

"There is a clear and significant benefit to universal screening for carbon monoxide, especially during the winter months, when carbon monoxide poisoning is most common,” said lead author Selim Suner, M.D., M.S., director of emergency preparedness and disaster medicine at Rhode Island Hospital. "Unless you have a carbon monoxide detector, it's extremely difficult to know if you're being exposed to toxic levels of this gas. If we can identify these cases of unsuspected poisoning early on, we can administer treatment and prevent them and others from being further exposed.”

CO exposure is the leading cause of accidental poisoning deaths in the United States, responsible for an estimated 15,000 emergency department visits and 500 unintentional deaths each year, mostly in winter. CO is an odorless, colorless gas produced by common household appliances that burn fuel, such as gasoline, oil, and wood. When not properly ventilated or used incorrectly, CO emitted by these appliances can build up to dangerous levels. CO poisoning can be very difficult to diagnose, since its symptoms resemble those of the flu and other common illnesses. Pregnant women, children, and the elderly are most susceptible to carbon monoxide poisoning.


Related Links:
Rhode Island Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.